NOTE TO THE FILE
SERIAL NUMBER: 88276451
DATE: 02/03/2020
NAME: chiser
NOTE:
Searched:
Lexis/Nexis
OneLook
Wikipedia
Acronym Finder Protest evidence reviewed
Other:Checked:
Geographic significance
Surname
Translation
ID with ID/CLASS mailboxChecked list of approved Canadian attorneys and agents
Discussed file with
Attorney/Applicant via:
X phone Left message with
X email Attorney/ApplicantRequested Law Library search X Issued Examiner’s Amendment
for: and entered changes in TRADEUPSPRINT DO NOT PRINT Added design code in TRADEUPS
Description of the mark
Translation statement Re-imaged standard character
drawing
Negative translation statement
Consent of living individual Contacted TM MADRID ID/CLASS
about misclassified definite ID
Changed TRADEUPS to:X OTHER:
Dear Charlie,
Thanks so much for your quick response. I confirm that you may proceed with an Examiner’s Amendment deleting Class 5 from the referenced application for OSTEOVANT, and approving it to proceed in Classes 42 and 44.
I look forward to receiving the Examiner’s Amendment at your earliest convenience. Please let me know if you have any questions.
Best regards,
Joyce
Joyce M. Ferraro | Counsel
Fross Zelnick Lehrman & Zissu, P.C.
151 West 42nd St., 17th Fl. | New York, NY 10036
T 212.813.8230 | F 212.813.5901
From: Hiser, Charles [mailto:Charles.Hiser@USPTO.GOV]
Sent: Monday, February 03, 2020 6:59 PM
To: Joyce Ferraro <jferraro@fzlz.com>
Subject: Re: US Trademark Application 88276451 (OSTEOVANT)
Dear Joyce,
I hope this email finds you well. I can do an examiner’s amendment wherein I just delete Class 5 from the application and approve it with Classes 42 and 44. If that is how you all would like to proceed just let me know by return email and I will go ahead and take care of it for you all.
Thanks,
Charlie
Charles H. Hiser IV
Trademarks Examining Attorney
Law Office 130
United States Patent & Trademark Office
(571) 272-7526
Notice to trademark applicants and attorneys: All relevant e-mail communications will be uploaded to the official application record in accordance with 37 C.F.R. §2.191 and TMEP §§709.04 - .05.
The information contained in this email message may be privileged, confidential, and protected from disclosure. Any unauthorized use, printing, copying, disclosure or dissemination of this communication may be subject to legal restriction or sanction. If you think that you have received this email message in error, please reply to the sender.